Microdetermination of prostaglandins and thromboxane B2 by capillary gas chromatography and negative ion chemical ionization mass spectrometry. 1984

H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori

Application of dimethyl-n- propylsilyl ( DMnPS ) ether derivatives of prostaglandins (PGs) and thromboxane (TX) B2 pentafluorobenzul ( PFB ) esters of negative ion chemical ionization mass spectrometry ( NICIMS ) was investigated. These derivatives were separated completely within 10 min by the use of a fused-silica capillary column coated with methyl silicone. In NICIMS , all of the DMnPS ether derivatives of PGs and TXB2 PFB esters yielded the characteristic negative ion [M - 181]- which was produced by elimination of PFB from the molecule. The detection limit of the DMnPS ether derivative of PGF2 alpha PFB ester was found to be 200 fg with a signal-to-noise ratio of 5 when monitoring the ion of m/z 653 ([M - 181]-) in the high-resolution mode (R = 2500) using ammonia as a reagent gas. The method was applied to the quantitation of PGE2 and PGF2 alpha in an extract obtained from the plasma of a lung-heart preparation from a dog.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008832 Microchemistry The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane

Related Publications

H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
February 1993, Analytical biochemistry,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
November 1988, Journal of chromatography,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
June 1990, Journal of chromatography,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
April 1983, Research communications in chemical pathology and pharmacology,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
May 1994, Analytical biochemistry,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
August 1985, Journal of chromatography,
H Miyazaki, and M Ishibashi, and H Takayama, and K Yamashita, and I Suwa, and M Katori
November 1985, Journal of chromatography,
Copied contents to your clipboard!